HealthEquity 上调 2025 财年每股收益和收入展望;分析师维持不同的观点，“适度买入”共识为 103.83 美元。 HealthEquity raises fiscal year 2025 EPS and revenue outlook; analysts maintain mixed views and a "Moderate Buy" consensus at $103.83.

美国健康股权公司 (NASDAQ:HQY) 更新了其2025财年展望,预计每股收益为2.98-3.14美元,收入为1165至1.185亿美元. HealthEquity, Inc. (NASDAQ: HQY) has updated its fiscal year 2025 outlook, projecting EPS of 2.98-3.14 and revenue of $1.165-1.185 billion. 最近,它报告说,Q2收入为0.55 EPS,超过估计数。 Recently, it reported Q2 earnings of $0.55 EPS, exceeding estimates. 分析师们的观点各不相同, 目标价格在92美元至110美元之间, "适度购买"的评级为103.83美元. Analysts have mixed views, with price targets ranging from $92 to $110, and a consensus rating of "Moderate Buy" at $103.83. 值得注意的是,副主席斯蒂芬·内埃莱曼最近出售了35 000股股票。 Notably, Vice Chairman Stephen Neeleman sold 35,000 shares recently. 该公司的市场上限为69.2亿美元。 The company has a market cap of $6.92 billion.